The ethical and legal implications of deactivating an implantable cardioverter‐defibrillator in a patient with terminal cancer
AUTOR(ES)
England, Ruth
FONTE
BMJ Group
RESUMO
In this paper, the ethical and legal issues raised by the deactivation of implantable cardioverter‐defibrillators (ICDs) in patients with terminal cancer is considered. It is argued that the ICD cannot be well described either as a treatment or as a non‐treatment option, and thus raises complex questions regarding how rules governing deactivation should be framed. A new category called “integral devices” is proposed. Integral devices require their own special rules, reflecting their position as a “halfway house” between a form of treatment and a part of the body. The practical problems faced by doctors working in palliative medicine with regard to the deactivation of ICDs are also considered.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2598190Documentos Relacionados
- Migration of an implantable cardioverter-defibrillator generator into the small bowel.
- Defibrillator twiddler's syndrome: a rare cause of implantable cardioverter-defibrillator failure.
- Migration of an automatic implantable cardioverter-defibrillator patch causing massive hemothorax.
- Right sided pectoral implantation of an "active can" transvenous implantable cardioverter-defibrillator with single right ventricular lead.
- Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.
